文献速递血液净化与透析肾移植

肾衰竭患者肾脏替代治疗轨迹:一项ERA登记研究

Kidney replacement therapy trajectories of patients with kidney failure: an ERA Registry study.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

结果显示69.6%的患者维持初始治疗模式至死亡或随访终点,最常见的轨迹为血液透析后死亡(53.4%)和血液透析转肾移植(10.2%)。治疗模式转换次数和方向因年龄、原发肾病、国家和初始模式而异,但无性别差异。

要点

  • 69.6%患者维持初始肾脏替代治疗模式至死亡或10年随访终点。
  • 最常见轨迹为血液透析后死亡(53.4%)和血液透析转肾移植(10.2%)。
  • 年轻患者和初始腹膜透析患者治疗模式转换更多,轨迹因年龄和原发肾病而异。

核心结论

  • 肾脏替代治疗模式转换次数和方向因年龄、原发肾病、国家和初始模式而异,但无性别差异。

主要发现

  • 69.6%的患者维持初始肾脏替代治疗模式至死亡或10年随访终点。
  • 最常见轨迹为血液透析后死亡(53.4%)、血液透析转肾移植(10.2%)、维持血液透析10年(5.6%)、腹膜透析后死亡(4.4%)和腹膜透析转肾移植(2.9%)。
  • 年轻患者和初始腹膜透析患者治疗模式转换更多;轨迹因年龄和原发肾病而异,不同欧洲国家间也有差异,但性别间无差异。

临床怎么用

  • 临床可参考常见轨迹(如血液透析后死亡占53.4%)对肾衰竭患者进行预后沟通和模式选择。
  • 对年轻和初始腹膜透析患者应关注更高的模式转换可能,提前规划治疗路径。

局限性

  • 研究为登记数据库分析,轨迹定义和事件报告可能受数据完整性影响。
  • 未进一步分析年轻血液透析患者死亡或长期维持血液透析未移植等特殊亚组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Trajectories of patients receiving kidney replacement therapy (KRT), including transitions between hemodialysis (HD), peritoneal dialysis (PD) and kidney transplantation (KTx), may vary across patient subgroups and have not yet been investigated in Europe. This study aimed to: (i) describe the number of shifts across KRT modalities; and (ii) characterize the most frequent patient trajectories, including the direction of shifts across KRT modalities, the duration spent on each modality, and patient events, including death. METHODS: Data of adult patients (≥20 years) who initiated KRT between 2004 and 2013 were extracted from the European Renal Association (ERA) Registry database and patients were followed for 10 years from the moment of KRT initiation. Results were stratified by age, sex, primary renal disease (PRD), country and initial KRT modality. RESULTS: Among 289 323 patients, more than two-thirds (69.6%) remained on their initial KRT modality until death or the end of 10 years follow-up, but younger patients and patients who initiated with PD had more shifts across KRT modalities than others. Overall, the most frequent patient trajectories were HD followed by death (53.4%), HD to KTx (10.2%), remaining on HD for 10 years (5.6%), PD followed by death (4.4%) and PD to KTx (2.9%). The most frequent patient trajectories differed between age and PRD groups, and across European countries, but not between women and men. CONCLUSION: The number and direction of shifts across KRT modalities varied by age, PRD, country and initial KRT modality, but not by sex. Future research should further investigate trajectories of patient subgroups that stood out, including young HD patients who died on their initial KRT modality and those who remained on HD for 10 years without undergoing KTx.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Boerstra BA, Kramer A, Jager KJ, et al. Kidney replacement therapy trajectories of patients with kidney failure: an ERA Registry study. Nephrol Dial Transplant. 2026. PMID: 41183509. doi:10.1093/ndt/gfaf236

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。